AIP
XBI icon

Ahrens Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ahrens Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$195K Sell
2,555
-75
-3% -$6.22K 0.1% 149
2022
Q4 		$218K Buy
+2,630
New +$213K 0.1% 149
2022
Q3 		– Sell
-3,455
Closed -$257K – 929
2022
Q2 		$257K Sell
3,455
-3,068
-47% -$230K 0.11% 140
2022
Q1 		$586K Buy
6,523
+4,668
+252% +$431K 0.18% 90
2021
Q4 		$208K Sell
1,855
-1,965
-51% -$237K 0.09% 178
2021
Q3 		$480K Sell
3,820
-175
-4% -$22.5K 0.23% 108
2021
Q2 		$541K Sell
3,995
-615
-13% -$80.9K 0.25% 108
2021
Q1 		$625K Buy
4,610
+20
+0.4% +$2.99K 0.32% 92
2020
Q4 		$646K Buy
4,590
+1,100
+32% +$141K 0.35% 73
2020
Q3 		$389K Sell
3,490
-1,475
-30% -$165K 0.26% 87
2020
Q2 		$556K Buy
+4,965
New +$489K 0.34% 64
2019
Q2 		– Sell
-2,293
Closed -$208K – 174
2019
Q1 		$208K Sell
2,293
-600
-21% -$51K 0.09% 140
2018
Q4 		$208K Sell
2,893
-4,200
-59% -$338K 0.1% 136
2018
Q3 		$680K Buy
7,093
+3,158
+80% +$306K 0.26% 73
2018
Q2 		$375K Sell
3,935
-135
-3% -$12.4K 0.16% 93
2018
Q1 		$357K Sell
4,070
-965
-19% -$88.1K 0.15% 93
2017
Q4 		$427K Buy
5,035
+160
+3% +$13.4K 0.17% 84
2017
Q3 		$422K Buy
4,875
+1,505
+45% +$121K 0.18% 79
2017
Q2 		$260K Hold
3,370
– – 0.11% 108
2017
Q1 		$234K Sell
3,370
-5,252
-61% -$353K 0.11% 110
2016
Q4 		$510K Buy
+8,622
New +$532K 0.27% 63

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ahrens Investment Partners's XBI Position: Q1 2023 in Review

Ahrens Investment Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.9% in Q1 2023, selling an estimated $6.22K and leaving 2,555 shares worth $195K. The position accounts for 0.1% of the portfolio, ranked #149.

Ahrens Investment Partners first reported a position in XBI in Q4 2016 and has held it in 21 quarters since. The position peaked at $680K in Q3 2018. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

  • Ahrens Investment Partners held 2,555 shares of State Street SPDR S&P Biotech ETF worth $195K as of Q1 2023.
  • Ahrens Investment Partners sold 75 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $6.22K.
  • State Street SPDR S&P Biotech ETF made up 0.1% of Ahrens Investment Partners's portfolio in Q1 2023, its #149 holding.
  • Ahrens Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 21 quarters since.
  • Ahrens Investment Partners's State Street SPDR S&P Biotech ETF position peaked at $680K in Q3 2018.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.